<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: We hypothesized that <z:mpath ids='MPATH_124'>infarct</z:mpath> transmurality assessed with late <z:chebi fb="0" ids="33375">gadolinium</z:chebi> enhancement cardiac magnetic resonance (LGE-CMR) predicts arrhythmic events in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>BACKGROUND: Patients with decreased left ventricular function due to <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> are at increased risk for life-threatening <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> related to infarcted tissue </plain></SENT>
<SENT sid="2" pm="."><plain>LGE-CMR accurately detects <z:mpath ids='MPATH_124'>infarct</z:mpath> <z:mp ids='MP_0000002'>morphology</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We prospectively enrolled 52 patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> referred for primary preventive implantable cardioverter-defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) implantation following MADIT (Multicenter Automatic Defibrillator Implantation Trial) study criteria </plain></SENT>
<SENT sid="4" pm="."><plain>Using LGE-CMR, left ventricular volumes, function, and <z:mpath ids='MPATH_124'>infarct</z:mpath> <z:mp ids='MP_0000002'>morphology</z:mp> were assessed including calculation of total and relative <z:mpath ids='MPATH_124'>infarct</z:mpath> mass, <z:mpath ids='MPATH_124'>infarct</z:mpath> border, <z:mpath ids='MPATH_124'>infarct</z:mpath> border zone, and <z:mpath ids='MPATH_124'>infarct</z:mpath> transmurality </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Patients were followed for 1,235 ± 341 days </plain></SENT>
<SENT sid="6" pm="."><plain>The primary combined endpoint including appropriate device therapy (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> discharge or antitachycardia pacing) or <z:hpo ids='HP_0011420'>death</z:hpo> from cardiac cause occurred in 16 individuals resulting in an annual event rate of 4.7% </plain></SENT>
<SENT sid="7" pm="."><plain>Six patients received an appropriate shock, 7 patients received recurrent appropriate antitachycardia pacing for sustained <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo>, and 3 patients died of cardiac cause </plain></SENT>
<SENT sid="8" pm="."><plain>There was a significant association to relative <z:mpath ids='MPATH_124'>infarct</z:mpath> mass (38 ± 8% vs. 28 ± 14%, p = 0.02), <z:mpath ids='MPATH_124'>infarct</z:mpath> transmurality (24 ± 8 g vs. 16 ± 12 g, p = 0.02), and relative <z:mpath ids='MPATH_124'>infarct</z:mpath> transmurality (RIT) (63 ± 12% vs. 48 ± 23%, p = 0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>In separate logistic regression models, no variable emerged as significant when combined with RIT </plain></SENT>
<SENT sid="10" pm="."><plain>As a single effect, RIT emerged as a predictor of the primary endpoint (p = 0.02) </plain></SENT>
<SENT sid="11" pm="."><plain>A RIT cutoff at 43% resulted in a sensitivity of 88%, a specificity of 50%, a positive predictive value of 44%, and a negative predictive value of 90% </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: In patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> scheduled for primary preventive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation, <z:mpath ids='MPATH_124'>infarct</z:mpath> transmurality as defined by LGE-CMR identifies a subgroup with increased risk for life-threatening <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> and cardiac <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
</text></document>